Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres
- PMID: 23885971
- PMCID: PMC3733999
- DOI: 10.1186/2191-219X-3-57
Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres
Abstract
Background: Coincidence imaging of low-abundance yttrium-90 (90Y) internal pair production by positron emission tomography with integrated computed tomography (PET/CT) achieves high-resolution imaging of post-radioembolization microsphere biodistribution. Part 2 analyzes tumor and non-target tissue dose-response by 90Y PET quantification and evaluates the accuracy of tumor 99mTc macroaggregated albumin (MAA) single-photon emission computed tomography with integrated CT (SPECT/CT) predictive dosimetry.
Methods: Retrospective dose quantification of 90Y resin microspheres was performed on the same 23-patient data set in part 1. Phantom studies were performed to assure quantitative accuracy of our time-of-flight lutetium-yttrium-oxyorthosilicate system. Dose-responses were analyzed using 90Y dose-volume histograms (DVHs) by PET voxel dosimetry or mean absorbed doses by Medical Internal Radiation Dose macrodosimetry, correlated to follow-up imaging or clinical findings. Intended tumor mean doses by predictive dosimetry were compared to doses by 90Y PET.
Results: Phantom studies demonstrated near-perfect detector linearity and high tumor quantitative accuracy. For hepatocellular carcinomas, complete responses were generally achieved at D70 > 100 Gy (D70, minimum dose to 70% tumor volume), whereas incomplete responses were generally at D70 < 100 Gy; smaller tumors (<80 cm3) achieved D70 > 100 Gy more easily than larger tumors. There was complete response in a cholangiocarcinoma at D70 90 Gy and partial response in an adrenal gastrointestinal stromal tumor metastasis at D70 53 Gy. In two patients, a mean dose of 18 Gy to the stomach was asymptomatic, 49 Gy caused gastritis, 65 Gy caused ulceration, and 53 Gy caused duodenitis. In one patient, a bilateral kidney mean dose of 9 Gy (V20 8%) did not cause clinically relevant nephrotoxicity. Under near-ideal dosimetric conditions, there was excellent correlation between intended tumor mean doses by predictive dosimetry and those by 90Y PET, with a low median relative error of +3.8% (95% confidence interval, -1.2% to +13.2%).
Conclusions: Tumor and non-target tissue absorbed dose quantification by 90Y PET is accurate and yields radiobiologically meaningful dose-response information to guide adjuvant or mitigative action. Tumor 99mTc MAA SPECT/CT predictive dosimetry is feasible. 90Y DVHs may guide future techniques in predictive dosimetry.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3733999/bin/2191-219X-3-57-1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3733999/bin/2191-219X-3-57-2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3733999/bin/2191-219X-3-57-3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3733999/bin/2191-219X-3-57-4.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3733999/bin/2191-219X-3-57-5.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3733999/bin/2191-219X-3-57-6.gif)
![Figure 7](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3733999/bin/2191-219X-3-57-7.gif)
Similar articles
-
Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.J Nucl Med. 2016 Nov;57(11):1672-1678. doi: 10.2967/jnumed.116.173104. Epub 2016 Jun 15. J Nucl Med. 2016. PMID: 27307346
-
Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization.J Nucl Med. 2012 Apr;53(4):559-66. doi: 10.2967/jnumed.111.097469. Epub 2012 Feb 17. J Nucl Med. 2012. PMID: 22343503
-
High quality imaging and dosimetry for yttrium-90 (90Y) liver radioembolization using a SiPM-based PET/CT scanner.Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2426-2436. doi: 10.1007/s00259-021-05188-4. Epub 2021 Jan 14. Eur J Nucl Med Mol Imaging. 2021. PMID: 33443618
-
90Y-Loaded Microsphere SIRT of HCC Patients With Portal Vein Thrombosis: High Clinical Impact of 99mTc-MAA SPECT/CT-Based Dosimetry.Semin Nucl Med. 2019 May;49(3):218-226. doi: 10.1053/j.semnuclmed.2019.01.006. Epub 2019 Feb 7. Semin Nucl Med. 2019. PMID: 30954188 Review.
-
Dosimetry of Y-90 Microspheres Utilizing Tc-99m SPECT and Y-90 PET.Semin Nucl Med. 2019 May;49(3):211-217. doi: 10.1053/j.semnuclmed.2019.01.005. Epub 2019 Jan 31. Semin Nucl Med. 2019. PMID: 30954187 Review.
Cited by
-
An international phantom study of inter-site variability in Technetium-99m image quantification: analyses from the TARGET radioembolization study.EJNMMI Phys. 2024 May 29;11(1):46. doi: 10.1186/s40658-024-00647-x. EJNMMI Phys. 2024. PMID: 38809320 Free PMC article.
-
Prospective comparison of positron emission tomography (PET)/magnetic resonance and PET/computed tomography dosimetry in hepatic malignant neoplastic disease after 90Y radioembolization treatment.J Gastrointest Oncol. 2024 Feb 29;15(1):356-367. doi: 10.21037/jgo-23-890. Epub 2024 Feb 26. J Gastrointest Oncol. 2024. PMID: 38482235 Free PMC article.
-
Liver Tumor Enhancement at Hybrid Angio-CT and Comparison With Tumor and Hepatic Parenchymal Distribution of Yttrium-90 Microspheres by Positron Emission Tomography.Cureus. 2023 Dec 3;15(12):e49861. doi: 10.7759/cureus.49861. eCollection 2023 Dec. Cureus. 2023. PMID: 38169929 Free PMC article.
-
AAPM Medical Physics Practice Guideline 14.a: Yttrium-90 microsphere radioembolization.J Appl Clin Med Phys. 2024 Feb;25(2):e14157. doi: 10.1002/acm2.14157. Epub 2023 Oct 11. J Appl Clin Med Phys. 2024. PMID: 37820316 Free PMC article.
-
99mTc-macroaggregated albumin SPECT/CT predictive dosimetry and dose-response relationship in uveal melanoma liver metastases treated with first-line selective internal radiation therapy.Sci Rep. 2023 Aug 12;13(1):13118. doi: 10.1038/s41598-023-39994-7. Sci Rep. 2023. PMID: 37573346 Free PMC article.
References
-
- Kao YH, Steinberg JD, Tay YS, Lim GKY, Yan J, Townsend DW, Takano A, Burgmans MC, Irani FG, Teo TKB, Yeow TN, Gogna A, Lo RHG, Tay KH, Tan BS, Chow PKH, Satchithanantham S, Tan AEH, Ng DCE, Goh ASW. Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting. EJNMMI Res. 2013;3:56. doi: 10.1186/2191-219X-3-56. - DOI - PMC - PubMed
-
- Salem R, Lewandowski RJ, Gates VL, Nutting CW, Murthy R, Rose SC, Soulen MC, Geschwind JF, Kulik L, Kim YH, Spreafico C, Maccauro M, Bester L, Brown DB, Ryu RK, Sze DY, Rilling WS, Sato KT, Sangro B, Bilbao JI, Jakobs TF, Ezziddin S, Kulkarni S, Kulkarni A, Liu DM, Valenti D, Hilgard P, Antoch G, Muller SP, Alsuhaibani H. et al.Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol. 2011;3:265–278. doi: 10.1016/j.jvir.2010.10.029. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources